cannabis indica

Índice completo — página 65 de 77

Estudos 6.401 a 6.500 de 7.640, ordenados do mais recente ao mais antigo — nesta página, publicações de 2011 a 2010. Para buscar por termo ou combinar filtros, use o acervo com busca.

Estudos 6.401 a 6.500

  1. 2011

    Screening for Antiviral Activities of Isolated Compounds from Essential Oils

    FavorávelEstudo LaboratorialHerpesHerpes-Zóster
  2. 2011

    Sedative effects of vapor inhalation of the essential oil of Microtoena patchoulii and its related compounds

    FavorávelEstudo em AnimaisInsônia e Distúrbios do Sono
  3. 2011

    Serum A-FABP is increased and closely associated with elevated NT-proBNP levels in type 2 diabetic patients treated with rosiglitazone

  4. 2011

    Skeletal lipidomics: regulation of bone metabolism by fatty acid amide family

  5. 2011

    Sleep disturbance and the effects of extended-release zolpidem during cannabis withdrawal

  6. 2011

    Spontaneous regression of septum pellucidum/forniceal pilocytic astrocytomas--possible role of Cannabis inhalation.

    FavorávelMetanáliseCâncerCâncer — Cérebro
  7. 2011

    Subjective and physiological effects after controlled Sativex and oral THC administration

    InconclusivoEnsaio ClínicoAnsiedadePsicoseTetraidrocanabinol (THC)THC Farmacêutico+1
  8. 2011

    Substance use disorder among people with first-episode psychosis: a systematic review of course and treatment

    DesfavorávelMetanálise ClínicaDependência QuímicaPsicose
  9. 2011

    Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ9-THCV in animal models of Parkinson's disease

    FavorávelEstudo em AnimaisDoença de ParkinsonTetraidrocanabivarina (THCV)
  10. 2011

    Synthetic cannabinoid JWH-018 and psychosis: an explorative study

  11. 2011

    Synthetic delta-9-tetrahydrocannabinol elicits schizophrenia-like negative symptoms which are distinct from sedation

    FavorávelEnsaio Clínico Duplo-CegoIntoxicação por Cannabis SintéticaTHC Farmacêutico
  12. 2011

    Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects

    FavorávelMetanáliseCâncerAnsiedadeDepressão+2
  13. 2011

    Targeting cannabinoid receptors as a novel approach in the treatment of graft-versus-host disease: Evidence from an experimental murine model

  14. 2011

    Targets of curcumin

    FavorávelMetanáliseCâncerInflamaçãoDoenças Cardiovasculares (DCV)Cúrcuma+17
  15. 2011

    THC-methadone and THC-naltrexone interactions on discrimination, antinociception, and locomotion in rats

    FavorávelEstudo em AnimaisDorDor — CrônicaDependência — Opioides+1
  16. 2011

    The antimitogenic effect of the cannabinoid receptor agonist WIN55212-2 on human melanoma cells is mediated by the membrane lipid raft

    FavorávelEstudo LaboratorialCâncerCâncer — MelanomaCanabinoides Sintéticos WIN-x
  17. 2011

    The antinociceptive potency of N-arachidonoyl-dopamine (NADA) and its interaction with endomorphin-1 at the spinal level

    FavorávelEstudo em AnimaisDorInflamaçãoDor — CrônicaN-Araquidonoil Dopamina (NADA)+1
  18. 2011

    The cannabinoid receptor agonist delta-9-tetrahydrocannabinol does not affect visceral sensitivity to rectal distension in healthy volunteers and IBS patients

    InconclusivoEnsaio Clínico Duplo-CegoSíndrome do Intestino IrritávelHemorroidasTHC Farmacêutico
  19. 2011

    The cannabinoid receptor agonist THC attenuates weight loss in a rodent model of activity-based anorexia

    FavorávelEstudo em AnimaisAnorexia (perda de apetite)Anorexia NervosaTetraidrocanabinol (THC)
  20. 2011

    The Endocannabinoid System as Pharmacological Target Derived from Its CNS Role in Energy Homeostasis and Reward. Applications in Eating Disorders and Addiction

  21. 2011

    The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease

  22. 2011

    The endovanilloid/endocannabinoid system: a new potential target for osteoporosis therapy

    FavorávelMetanáliseOsteoporose
  23. 2011

    The fatty acid amide hydrolase (FAAH) gene variant rs324420 AA/AC is not associated with weight loss in a 1-year lifestyle intervention for obese children and adolescents

    InconclusivoEnsaio ClínicoObesidadeHidrolase de Amidas de Ácidos Graxos (FAAH)
  24. 2011

    The manifold actions of endocannabinoids on female and male reproductive events

    InconclusivoMetanáliseInfertilidade MasculinaEndocanabinoide (não especificado)
  25. 2011

    The multiplicity of action of cannabinoids: implications for treating neurodegeneration

  26. 2011

    The relationships of 'ecstasy' (MDMA) and cannabis use to impaired executive inhibition and access to semantic long-term memory

  27. 2011

    Therapeutic potential of cannabidiol against ischemia/reperfusion liver injury in rats

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)Lesão de Reperfusão
  28. 2011

    Therapeutic potential of the endocannabinoid system in perinatal asphyxia.

  29. 2011

    Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users

    InconclusivoEnsaio Clínico Duplo-CegoDependência QuímicaEfeitos Adversos da CannabisDependência — Cannabis+2
  30. 2011

    Too Many Mouldy Joints – Marijuana and Chronic Pulmonary Aspergillosis

    DesfavorávelMetanáliseInfecções Fúngicas
  31. 2011

    Treatment of Crohn's Disease With Cannabis: An Observational Study

  32. 2011

    Update and new trends in antiemetic therapy: the continuing need for novel therapies.

    FavorávelMetanáliseNáusea e VômitoNáusea e Vômito por Quimioterapia
  33. 2011

    WIN55,212-2 induces cytoplasmic vacuolation in apoptosis-resistant MCL cells

    FavorávelEstudo LaboratorialCâncerCâncer — LinfomaCanabinoides Sintéticos WIN-x
  34. 2011

    α-Terpineol reduces nociceptive behavior in mice.

    FavorávelEstudo em AnimaisDor
  35. 2011

    β-Caryophyllene Inhibits Dextran Sulfate Sodium-Induced Colitis in Mice through CB2 Receptor Activation and PPARγ Pathway.

  36. 2010

    [Cannabis and the lung - chill or kill?].

    FavorávelMetanálise ClínicaEfeitos Adversos da Cannabis
  37. 2010

    A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice

    FavorávelEstudo em AnimaisDorAnsiedadeDisfunção CognitivaTetraidrocanabinol (THC)+5
  38. 2010

    A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone loss

    FavorávelEstudo em AnimaisCâncerCâncer — ÓsseoCanabinoides Sintéticos AM-x
  39. 2010

    A cannabinoid CB(1) receptor antagonist ameliorates impairment of recognition memory on withdrawal from MDMA (Ecstasy)

    FavorávelEstudo em AnimaisEfeitos Adversos do MDMACanabinoides Sintéticos AM-x
  40. 2010

    A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study

    DesfavorávelEnsaio Clínico Duplo-CegoObesidadeCanabinoide Sintético (não especificado)
  41. 2010

    A clinical trial assessing the safety and efficacy of the CB1R inverse agonist taranabant in obese and overweight patients: low-dose study

    InconclusivoEnsaio Clínico Duplo-CegoObesidade
  42. 2010

    A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis

    FavorávelEnsaio Clínico Duplo-CegoEsclerose MúltiplaTHC:CBD Farmacêutico
  43. 2010

    A metabolically stable analogue of anandamide, Met-F-AEA, inhibits human thyroid carcinoma cell lines by activation of apoptosis.

  44. 2010

    A Multi-Center, Double-Blind, Randomised Study of the Lavender Oil Preparation Silexan in Comparison to Lorazepam for Generalized Anxiety Disorder

    FavorávelEnsaio Clínico Duplo-CegoAnsiedade
  45. 2010

    A one-year study to assess the safety and efficacy of the CB1R inverse agonist taranabant in overweight and obese patients with type 2 diabetes

    DesfavorávelEnsaio Clínico Duplo-CegoObesidadeDiabetes
  46. 2010

    A randomized trial of lifestyle modification and taranabant for maintaining weight loss achieved with a low-calorie diet

    InconclusivoEnsaio Clínico Duplo-CegoObesidade
  47. 2010

    A randomized, double-blinded, crossover pilot study assessing the effect of nabilone on spasticity in persons with spinal cord injury

    FavorávelEnsaio Clínico Duplo-CegoLesões da Medula EspinhalTetraidrocanabinol (THC)THC Farmacêutico
  48. 2010

    Activation Of Cannabinoid CB2 Receptor Ameliorates Atherosclerosis Associated With Suppression Of Adhesion Molecules

  49. 2010

    Activity-based anorexia in C57/BL6 mice: effects of the phytocannabinoid, Delta9-tetrahydrocannabinol (THC) and the anandamide analogue, OMDM-2

    InconclusivoEstudo em AnimaisAnorexia (perda de apetite)Anorexia Nervosa
  50. 2010

    Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion.

  51. 2010

    Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion.

  52. 2010

    Acute effects of MDMA (3,4-methylenedioxymethamphetamine) on EEG oscillations: alone and in combination with ethanol or THC (delta-9-tetrahydrocannabinol)

  53. 2010

    Acute psychotropic effects of oral cannabis extract with a defined content of Delta9-tetrahydrocannabinol (THC) in healthy volunteers

    DesfavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisDependência — Benzodiazepínicos
  54. 2010

    Adjuvant topical therapy with a cannabinoid receptor agonist in facial postherpetic neuralgia.

  55. 2010

    Alpha terpineol: a potential anticancer agent which acts through suppressing NF-kappaB signalling.

    FavorávelEstudo LaboratorialCâncerCâncer — Pulmão
  56. 2010

    Alterations of the endocannabinoid system in an animal model of migraine: evaluation in cerebral areas of rat

  57. 2010

    An open-label comparison of nabilone and gabapentin as adjuvant therapy or monotherapy in the management of neuropathic pain in patients with peripheral neuropathy

    FavorávelEnsaio ClínicoDorDor — Neuropatia PeriféricaTHC Farmacêutico
  58. 2010

    Anti-inflammatory effects of limonene from yuzu (Citrus junos Tanaka) essential oil on eosinophils.

    FavorávelEstudo LaboratorialInflamaçãoAsma
  59. 2010

    Anticonvulsant and anxiolytic evaluation of leaf extracts of Ocimum gratissimum, a culinary herb

    FavorávelEstudo em AnimaisAnsiedadeEpilepsia
  60. 2010

    Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.

    FavorávelEstudo em AnimaisDepressãoTetraidrocanabinol (THC)Canabigerol (CBG)+2
  61. 2010

    Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood

    FavorávelMetanálise ClínicaNáusea e VômitoNáusea e Vômito por Quimioterapia
  62. 2010

    Antinociceptive effect of the cannabinoid agonist, WIN 55,212-2, in the orofacial and temporomandibular formalin tests

    FavorávelEstudo em AnimaisDisfunção Temporomandibular (DTM)Canabinoides Sintéticos WIN-x
  63. 2010

    Antiproliferative Effects of Cannabinoid Agonists on Deep Infiltrating Endometriosis.

    FavorávelEstudo em AnimaisEndometrioseCanabinoides Sintéticos WIN-x
  64. 2010

    Are cannabis use disorders associated with an earlier age at onset of psychosis? A study in first episode schizophrenia

  65. 2010

    Assessment of medication adherence in a cohort of patients with bipolar disorder

    DesfavorávelEnsaio ClínicoEfeitos Adversos da CannabisPsicoseTranstorno Bipolar
  66. 2010

    Behavioural and molecular consequences of chronic cannabinoid treatment in Huntington's disease transgenic mice.

  67. 2010

    Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, inflammatory and cell death signaling pathways in diabetic cardiomyopathy.

    FavorávelEstudo em AnimaisInflamaçãoDoenças Cardiovasculares (DCV)Estresse Oxidativo+1
  68. 2010

    Cannabidiol Attenuates the Appetitive Effects of Δ9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis.

  69. 2010

    Cannabidiol Displays Antiepileptiform and Antiseizure Properties In Vitro and In Vivo.

    FavorávelEstudo em AnimaisEpilepsiaCanabinoides Sintéticos AM-xCanabinoides Sintéticos WIN-x+1
  70. 2010

    Cannabidiol Enhances The Inhibitory Effects Of Delta9-tetrahydrocannabinol On Human Glioblastoma Cell Proliferation And Survival

    FavorávelEstudo em AnimaisCâncerCâncer — CérebroTetraidrocanabinol (THC)
  71. 2010

    Cannabidiol Inhibits Cancer Cell Invasion Via Upregulation Of Tissue Inhibitor Of Matrix Metalloproteinases-1

    FavorávelEstudo em AnimaisCâncerCâncer — PulmãoCâncer — Metastático+1
  72. 2010

    Cannabidiol was ineffective for manic episode of bipolar affective disorder.

    InconclusivoEnsaio Clínico Duplo-CegoTranstorno Bipolar
  73. 2010

    Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease

    FavorávelMetanáliseInflamaçãoAnandamida (AEA)Tetraidrocanabinol (THC)+6
  74. 2010

    Cannabinoid CB1 Receptor Is Downregulated In Clear Cell Renal Cell Carcinoma

    FavorávelEstudo LaboratorialCâncerCâncer — Rim
  75. 2010

    Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: relevance for Huntington’s disease.

  76. 2010

    Cannabinoid hyperemesis

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  77. 2010

    Cannabinoid Inhibition of Macrophage Migration to the Trans-Activating (Tat) Protein of HIV-1 Is Linked to the CB2 Cannabinoid Receptor

  78. 2010

    Cannabinoid Receptors and Endocannabinoids: Role in Neuroinflammatory and Neurodegenerative Disorders

  79. 2010

    Cannabinoid Receptors as Target for Treatment of Osteoporosis: A Tale of Two Therapies

    FavorávelMetanáliseOsteoporose
  80. 2010

    Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress and cell death in nephropathy.

  81. 2010

    Cannabinoid-Induced Hyperemesis: A Conundrum—From Clinical Recognition to Basic Science Mechanisms

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  82. 2010

    Cannabinoids and bone: friend or foe?

  83. 2010

    Cannabinoids and Viral Infections.

    InconclusivoEstudo LaboratorialHIV/AIDSHepatiteHerpesAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+8
  84. 2010

    Cannabinoids Inhibit Cellular Respiration Of Human Oral Cancer Cells

    FavorávelEstudo LaboratorialCâncerCâncer — BocaTetraidrocanabinol (THC)
  85. 2010

    Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition

  86. 2010

    Cannabinoids, opioids and MDMA: neuropsychological interactions related to addiction

  87. 2010

    Cannabis And Amyotrophic Lateral Sclerosis: Hypothetical And Practical Applications, And A Call For Clinical Trials

    FavorávelEstudo em AnimaisEsclerose Lateral Amiotrófica (ELA)
  88. 2010

    Cannabis and hyperemesis

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  89. 2010

    Cannabis use and sexual health

    InconclusivoMetanáliseLibidoDisfunção Erétil
  90. 2010

    Cannabis-associated arteritis

  91. 2010

    CB1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model

  92. 2010

    Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy.

    FavorávelEnsaio ClínicoEpilepsiaAnandamida (AEA)2-Araquidonoilglicerol (2-AG)
  93. 2010

    Characteristics of pregnant illicit drug users and associations between cannabis use and perinatal outcome in a population-based study

    InconclusivoMetanáliseGestaçãoTrabalho de Parto e Complicações
  94. 2010

    Clinical and Experimental Pharmacology and Physiology Clinical and Experimental Pharmacology and Physiology Free Access Unravelling the cardiovascular effects induced by α-terpineol: A role for the nitric oxide–cGMP pathway

    InconclusivoEstudo em AnimaisDoenças Cardiovasculares (DCV)Hipertensão Arterial
  95. 2010

    Comparative Study on the Antiviral Activity of Selected Monoterpenes Derived From Essential Oils

    FavorávelEstudo LaboratorialHerpesDoenças PriônicasHerpes-Zóster
  96. 2010

    Decrease of plasminogen activator inhibitor-1 may contribute to the anti-invasive action of cannabidiol on human lung cancer cells

    FavorávelEstudo LaboratorialCâncerCâncer — Pulmão
  97. 2010

    Deficiency in Endocannabinoid Signaling in the Nucleus Accumbens Induced by Chronic Unpredictable Stress

    FavorávelEstudo em AnimaisDepressãoAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+2
  98. 2010

    Depression-like phenotype following chronic CB1 receptor antagonism.

  99. 2010

    Development of a population pharmacokinetic model for taranabant, a cannibinoid-1 receptor inverse agonist

    DesfavorávelMetanálise ClínicaObesidadeCanabinoide Sintético (não especificado)
  100. 2010

    Disposition of cannabichromene, cannabidiol, and Δ⁹-tetrahydrocannabinol and its metabolites in mouse brain following marijuana inhalation determined by high-performance liquid chromatography-tandem mass spectrometry

    FavorávelEstudo em AnimaisCanabicromeno (CBC)